NCT01864174 Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01860976 Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01858935 A Phase 1, Randomized, Double-Blind, Placebo-Controlled Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection in Normal Healthy Subjects Status COMPLETED Phase PHASE1
NCT01850004 Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response Status COMPLETED Phase PHASE2
NCT01846975 Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday Status COMPLETED Phase PHASE4
NCT01844895 Methotrexate-Inadequate Response Autoinjector Device Sub Study Status COMPLETED Phase PHASE3
NCT01844518 Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Status COMPLETED Phase PHASE3
NCT01844505 Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067) Status COMPLETED Phase PHASE3
NCT01841359 Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery Status COMPLETED Phase PHASE4
NCT01838512 Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01838200 Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma Status TERMINATED Phase PHASE1
NCT01837719 Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat Status COMPLETED Phase PHASE1
NCT01837043 Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function Status UNKNOWN Phase PHASE2
NCT01836705 Effect of SAR302503 on ECG Activity in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01835470 Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan Status COMPLETED Phase PHASE3
NCT01830205 Pharmacokinetic and Safety Study of Daclatasvir in Patients With Renal Impairment Status COMPLETED Phase PHASE1
NCT01820572 A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based Status COMPLETED Phase PHASE3
NCT01818856 Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir Status COMPLETED Phase PHASE1
NCT01804465 Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer Status COMPLETED Phase PHASE2